Atossa Therapeutics
ATOS
#10613
Rank
HK$0.16 B
Marketcap
HK$16.23
Share price
-5.48%
Change (1 day)
152.20%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): -HK$30.95

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$31.05. In 2025 the company made an earnings per share (EPS) of -HK$31.68 a decrease over its 2024 EPS that were of -HK$23.84.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$30.95-2.31%
2025-HK$31.6832.89%
2024-HK$23.84-15.56%
2023-HK$28.2314.29%
2022-HK$24.7016.67%
2021-HK$21.17-90.86%
2020-HK$231.73-2.96%
2019-HK$238.79-63.09%
2018-HK$646.97-49.63%
2017-HK$1,285-57.87%
2016-HK$3,049-74.01%
2015-HK$11,730-9.18%
2014-HK$12,916-12.86%
2013-HK$14,82170.73%
2012-HK$8,68134.07%
2011-HK$6,475263.41%
2010-HK$1,782

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.50-320.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$71.91-331.57%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$89.09-386.87%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$6.04-80.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.65-94.70%๐Ÿ‡บ๐Ÿ‡ธ USA